Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711 von Lindström, Erik, Rizoska, Biljana, Henderson, Ian, Terelius, Ylva, Jerling, Markus, Edenius, Charlotte, Grabowska, Urszula

Volltext

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients von Paul, Gesine, Zachrisson, Olof, Varrone, Andrea, Almqvist, Per, Jerling, Markus, Lind, Göran, Rehncrona, Stig, Linderoth, Bengt, Bjartmarz, Hjalmar, Shafer, Lisa L, Coffey, Robert, Svensson, Mikael, Mercer, Katarina Jansson, Forsberg, Anton, Halldin, Christer, Svenningsson, Per, Widner, Håkan, Frisén, Jonas, Pålhagen, Sven, Haegerstrand, Anders

Volltext

Clinical pharmacokinetics of ranolazine von JERLING, Markus

Volltext

Effect of Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ranolazine Sustained-Release Tablets von Abdallah, Hisham, Jerling, Markus

Volltext

Studies to Investigate the Pharmacokinetic Interactions Between Ranolazine and Ketoconazole, Diltiazem, or Simvastatin During Combined Administration in Healthy Subjects von Jerling, Markus, Huan, Bee-Lian, Leung, Kwan, Chu, Nancy, Abdallah, Hisham, Hussein, Ziad

Volltext

A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer von Sahin, Ugur, Schuler, Martin, Richly, Heike, Bauer, Stefan, Krilova, Anna, Dechow, Tobias, Jerling, Markus, Utsch, Magdalena, Rohde, Christoph, Dhaene, Karl, Huber, Christoph, Türeci, Özlem

Volltext

Insights on Nefecon ® , a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy von Barratt, Jonathan, Kristensen, Jens, Pedersen, Christian, Jerling, Markus

Volltext

PORT (OP-109): Phase 2, Randomized, Pharmacokinetic (PK), Cross-over Study of Peripheral Vs Central Intravenous Administration of Melflufen in Patients with Relapsed/Refractory Mul... von Minarik, Jiri, Micheva, Ilina, Usenko, Ganna, Mikala, Gabor, Simeonova, Kameliya, Thuresson, Marcus, Jerling, Markus, Xie, Hanjing, Pour, Ludek

Volltext

Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide–Drug Conjugate, in Patients with Relapsed Refractory Multiple Myeloma von Huledal, Gunilla, Ruiz‐Garcia, Ana, Kawakatsu, Sonoko, Wang, Xiaoning, Sjöberg, Per, Gullbo, Joachim, Pekar, David, Norin, Stefan, Jerling, Markus

Volltext

Melflufen - a peptidase-potentiated alkylating agent in clinical trials von Wickström, Malin, Nygren, Peter, Larsson, Rolf, Harmenberg, Johan, Lindberg, Jakob, Sjöberg, Per, Jerling, Markus, Lehmann, Fredrik, Richardson, Paul, Anderson, Kenneth, Chauhan, Dharminder, Gullbo, Joachim

Volltext

P-205: PORT (OP-109): Phase 2, randomised, Pharmacokinetic (PK), cross-over study of peripheral vs central intravenous administration of Melflufen in patients with Relapsed/Refract... von Minarik, Jiri, Micheva, Ilina, Usenko, Ganna, Mikala, Gábor, Masszi, Tamas, Simeonova, Kameliya, Andersson, Birgitta, Jerling, Markus, Xie, Hanjing, Pour, Luděk

Volltext

Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung canc... von Bergqvist, Michael, Holgersson, Georg, Bondarenko, Igor, Grechanaya, Elena, Maximovich, Alexey, Andor, György, Klockare, Maria, Thureson, Marcus, Jerling, Markus, Harmenberg, Johan

Volltext

Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine von Jerling, Markus, Abdallah, Hisham

Volltext

First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies von Berglund, Åke, Ullén, Anders, Lisyanskaya, Alla, Orlov, Sergey, Hagberg, Hans, Tholander, Bengt, Lewensohn, Rolf, Nygren, Peter, Spira, Jack, Harmenberg, Johan, Jerling, Markus, Alvfors, Carina, Ringbom, Magnus, Nordström, Eva, Söderlind, Karin, Gullbo, Joachim

Volltext

Oil‐Fortified Maize Porridge Increases Absorption of Lumefantrine in Children with Uncomplicated Falciparum Malaria von Mwebaza, Norah, Jerling, Markus, Gustafsson, Lars L., Silva, Antero V., Pohanka, Anton, Obua, Celestino, Waako, Paul, Beck, Olof, Homann, Manijeh Vafa, Färnert, Anna, Hellgren, Urban

Volltext

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial von Ekman, Simon, Harmenberg, Johan, Frödin, Jan-Erik, Bergström, Stefan, Wassberg, Cecilia, Eksborg, Staffan, Larsson, Olle, Axelson, Magnus, Jerling, Markus, Abrahmsen, Lars, Hedlund, Åsa, Alvfors, Carina, Ståhl, Birgitta, Bergqvist, Michael

Volltext

Pronounced differences in the disposition of clomipramine between Japanese and Swedish patients von SHIMODA, K, JERLING, M, BÖTTIGER, Y, YASUDA, S, MORITA, S, BERTILSSON, L

Volltext

Effects of intranasal kinetic oscillation stimulation on heart rate variability von Jerling, Markus, Cygankiewicz, Iwona, Al‐Tawil, Nabil, Darpo, Borje, Ljungström, Anders, Zareba, Wojciech

Volltext

Intracerebroventricular delivery of vascular endothelial growth factor in patients with amyotrophic lateral sclerosis, a phase I study von Van Damme, Philip, Tilkin, Petra, Mercer, Katarina Jansson, Terryn, Joke, D’Hondt, Ann, Herne, Nina, Tousseyn, Thomas, Claeys, Kristl G, Thal, Dietmar R, Zachrisson, Olof, Almqvist, Per, Nuttin, Bart, Jerling, Markus, Bernadotte, Folke, Haegerstrand, Anders, Robberecht, Wim

Volltext

A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally ad... von Holgersson, Georg, Bergström, Stefan, Harmenberg, Johan, Ringbom, Magnus, Klockare, Maria, Jerling, Markus, Ekman, Simon, Lundström, Kristina Lamberg, Koyi, Hirsh, Brandén, Eva, Larsson, Olle, Bergqvist, Michael

Volltext